Form D · Other
InjectSense, Inc.
Emeryville, CA · CIK 0001717613
Offering snapshot reported Apr 23, 2019 · SEC filing
- Reported sold
- $4.09M Offering amount: $8.44M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 9, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 23, 2019 | Initial | $4,090,343 | No comparison | 23 | SEC filing |
| Oct 11, 2017 | Initial | $9,836,021 | No comparison | 42 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-337938
Actual Total Offering Amount is $8,437,451.16. Actual Total Amount Sold is $4,090,342.56. Actual Remaining to be Sold is $4,347,108.60.
Source: Form D, filed Apr 23, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ariel Cao | Director, Executive |
| Enrique Malaret | Director, Executive |
| Zack Scott | Director |
Issuer details
Industry: Other (See others in industry)
Address:
2000 Powell St. Suite 1425
Emeryville, CA, 94608
Emeryville, CA, 94608